Sweden· SE-20220627000137
Sogroya 15 mg/1,5 ml Injektionsvätska, lösning i förfylld injektionspenna
A medicinal product containing somapacitan, registered in Sweden by Novo Nordisk A/S.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Somapacitan
- Manufacturer
- Novo Nordisk A/S
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20220627000137
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Somapacitan in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaSOGROYANovo Nordisk A/S, Bagsvaerd
- BelgiumSogroya 15 mg/1.5 mlNovo Nordisk
- SwitzerlandSogroya 15 mg/ 1.5 ml, Injektionslösung im FertigpenNovo Nordisk Pharma AG
- SpainSOGROYA 15 MG/1,5 ML SOLUCION INYECTABLE EN PLUMA PRECARGADANovo Nordisk A/S
- PolandSogroyaNovo Nordisk A/S
- CanadaSOGROYANOVO NORDISK CANADA INC
- FinlandSogroyaNovo Nordisk A/S
- NetherlandsSogroya 10 mg/1,5 ml, oplossing voor injectie in een voorgevulde penNovo Nordisk A.S.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Sogroya
- Norway · Sogroya
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ddfb35a6-818c-4031-a217-46fbca0ae6ad GET /v1/drugs/ddfb35a6-818c-4031-a217-46fbca0ae6ad?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"EMA"
],
"se_npl_id": "20220627000137",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20220627000137",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/sogroya-epar-product-information_sv.pdf"
}See everything about somapacitan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.